Definitive Healthcare Corp.
DH · Price history
Price at last available close
$1.12
+$0.19 (+20.43%) 1M
2026-10-29
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Definitive Healthcare Corp.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U. S. healthcare industry.
How they make money
Definitive Healthcare generates revenue primarily through a subscription-based model, providing customers with access to its cloud-based healthcare commercial intelligence platform. Customers pay recurring fees for platform access, which includes data analytics, market intelligence, and insights to support their commercial strategies, sales, and marketing efforts within the healthcare ecosystem.
Products & services
The company provides a cloud-based healthcare commercial intelligence platform that offers data and analytics on healthcare providers, claims, and consumer insights to assist organizations in product development, go-to-market planning, and sales execution.
Brands & revenue mix
Primary brand for the company's healthcare commercial intelligence platform.
Separate brand revenue is not available in this research.Source
Specialized suite for expert identification and engagement.
Separate brand revenue is not available in this research.Source
Suite focused on consumer analytics and engagement.
Separate brand revenue is not available in this research.Source
Platform solution for healthcare commercial intelligence.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
Geographic revenue
Customer types
Customer concentration
The company does not report significant customer concentration, noting that its customer base is diversified across various sectors including life sciences, healthcare IT, and other professional services.
Suppliers, materials & equipment
- Cloud infrastructure and data hosting service providers — The company relies on third-party cloud infrastructure providers to host its platform and store data.Source
Competitors
- IQVIA — Competes in the provision of healthcare data, analytics, and commercial intelligence services.Source
- Clarivate — Competes in the provision of healthcare data, analytics, and commercial intelligence services.Source
- Veeva Systems — Competes in the provision of healthcare data, analytics, and commercial intelligence services.Source
Strengths
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
30
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
35
Poor
Financial Strength
54
Business Quality / Moat
46
Management
25
Growth Quality
12
Risk / Durability
7
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
31
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
39/100
Building Historical Record
Model Score 39/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Recent buyback activity is present
- •Debt service risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for DH
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving DH's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •Is DH's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Does DH's balance between cash and debt leave enough flexibility if business conditions weaken?
- •What specifically needs to improve for DH to reach sustainable profitability?
- •What future growth or profitability would be needed to justify DH's current valuation?
Essential Investment Snapshot
Wall Street Score
30
Opportunity Score
31
Market Cap
$119.6M
P/E Ratio
-0.6
EPS
$-1.60
52-Week High
$3.58
52-Week Low
$0.61
Beta
1.40
Analyst Target
$1.10
Shares Outstanding
106.7M
Total Revenue
$232.7M
Total Debt
$167.1M
Reported Dividend Yield
3.30%
Liquidation Value / Share
$1.76
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong upward momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for DH
Detected from reported data — verify before acting.Dividend history reported
The provider reports a dividend yield. Confirm the latest declaration before treating it as a current payment.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Debt service risk
Interest coverage is low (~-1.8x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on DH.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Comprehensive, proprietary healthcare commercial intelligence platform.
- +High-quality, integrated data sets covering the healthcare ecosystem.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
- −Dependence on third-party data sources and potential data quality issues.
- −Intense competition in the healthcare data and analytics market.
- −Risks related to data privacy and security regulations.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
6 historical score records availablePrevious Score
30
Sep 17, 2026
Change
Unchanged
Current Score
30
Oct 1, 2026
Category Changes
DH score was unchanged.
Projected Score
Projected Score
27
Projected Change
-3.2 points
Preliminary comparable-period financial changes suggest decline of approximately 3.2 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$1.12
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $232.7M | $241.5M | $252.2M | $251.4M | ···· | ···· | ···· | ···· |
| Cost of Revenue | $65.9M | $58.2M | $54.7M | $47.5M | ···· | ···· | ···· | ···· |
| Gross Profit | $166.8M | $183.3M | $197.5M | $203.9M | ···· | ···· | ···· | ···· |
| Research & Development | $24.0M | $34.8M | $36.5M | $42.4M | ···· | ···· | ···· | ···· |
| SG&A Expenses | $128.8M | $133.3M | $133.1M | $153.4M | ···· | ···· | ···· | ···· |
| Operating Expenses | $10.0M | $203.9M | $908.3M | $533.7M | ···· | ···· | ···· | ···· |
| EBITDA | -$190.4M | -$162.2M | -$567.2M | -$241.2M | ···· | ···· | ···· | ···· |
| Operating Income | $156.8M | -$20.6M | -$710.8M | -$329.8M | ···· | ···· | ···· | ···· |
| Interest Expense | $11.1M | $11.3M | $14.8M | $15.2M | ···· | ···· | ···· | ···· |
| Income Before Tax | -$238.1M | -$209.3M | -$633.7M | -$308.2M | ···· | ···· | ···· | ···· |
| Income Tax Expense | -$3.3M | -$10.0M | -$42.3M | -$18.6M | ···· | ···· | ···· | ···· |
| Net Income | -$168.2M | -$138.9M | -$413.1M | -$202.4M | ···· | ···· | ···· | ···· |
| Basic EPS | $-1.60 | $-1.30 | $-3.54 | $-1.79 | ···· | ···· | ···· | ···· |
| Basic Shares | 106M | 107M | 117M | 113M | ···· | ···· | ···· | ···· |
| Diluted Shares | 106M | 107M | 117M | 113M | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$55.2M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.05
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-6.1%
Cash Change
+111.0%
Margin Change
+2.6 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Cash position grew
- Debt reduced
Potential Score Impact
Positive indicators included cash levels, debt levels, net income margin. Pressure indicators included revenue growth, EPS growth. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 9.1%. EPS declined 29.3%. Cash increased 111.0%. Total debt declined 6.1%. Net income margin improved by 2.6 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
A dividend is reported, but detailed payment history is temporarily unavailable or awaiting refresh.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
6 historical recordsHistorical Score Chart
3 of 6 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Healthcare Information ServicesNews
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
Definitive Healthcare Appoints Clay Ritchey as CEO
Rumor Mill · DH
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial